Modern Interface, Same Old Problem?
The FDA’s Adverse Event Monitoring System (AEMS) illustrates the truth of Stoll and Wilson’s observations. While the agency is celebrating its consolidated, real-time dashboard as a modernization milestone, what the public needs is not just more data, but more action.











